EW's 30 day historical volatility is 24.92%, in the 47th percentile of readings over the past year. This is an average percentile, meaning Edwards Lifesciences Corp shares have moved roughly in line with their typical range. EW's 30 day implied volatility sits at 25.69%, with an IV Rank of 16.27%, leaving IV roughly in line with historical volatility. This means options are priced close to what the stock has actually delivered, as of Nov 13, 2026.

Tracking EW historical volatility helps you see how much Edwards Lifesciences Corp's stock price has actually moved, giving you a baseline for whether option premiums look fair, cheap, or expensive. While implied volatility shows what the market expects, EW's HV, also known as realized volatility, shows what actually happened. Use our scanner to monitor EW 30 day historical volatility alongside longer lookback windows and spot the moments when realized and implied diverge.

Historical volatility is the annualized standard deviation of a stock's past returns, typically measured over rolling windows like 10, 20, 30, or 60 days. EW's 30 day historical volatility, or EW HV, is one of the most widely watched readings because it balances responsiveness with stability. Comparing EW's HV to its implied volatility reveals the volatility risk premium. When IV sits well above HV, options are pricing in more movement than the stock has actually delivered, giving option sellers an edge. When HV runs hot relative to IV, options are pricing in less movement than the stock has delivered, and buyers may be underpaying for it.

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation.

Edwards Lifesciences Corp

Edwards Lifesciences Corp (EW) Historical Volatility

Historical Volatility